The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration

Published by: Business Insights

Published: Jan. 1, 2010 - 151 Pages

Table of Contents

The Future of Nutrigenomics

Executive summary

Defining nutrigenomics

Market drivers

Collaborative nutrigenomic research & consortia

Leading food & drinks companies: nutrigenomic strategies

Leading nutrigenomic testing companies

Opportunities: convergence of pharma & diagnostics

Challenges: regulation, ethical & IP issues

Conclusions

Chapter 1 Defining nutrigenomics

Summary

Introduction

‘Omic technologies

Nutrigenomics and the food & drinks industry

Nutrigenomics & food products

Nutrigenomics & personalized nutrition

Report outline

Chapter 2 Market drivers

Summary

Introduction

Drivers for personalized nutrition

Healthy aging

Consumer demographics

Chronic non-communicable disease

Urbanization and the emerging markets

Global health economics

Conclusions on drivers for personalized nutrition

Chapter 3 Collaborative nutrigenomic research & consortia

Summary

Introduction

Nutrigenomic research consortia

Nutrigenomic research in the EU

The European Nutrigenomics Organization (NuGO)

DiOGenes

TI Food and Nutrition

Vision EpiFood Project

Canada Foundation for Innovation (CFI)

Public-private in age-related diseases

Nutrigenomic research in the US

Public-private partnership: genetically modified crops

Nutrigenomic research across the world

International Society of Nutrigenetics/Nutrigenomics (ISNN)

Conclusions

Chapter 4 Leading food & drinks companies: nutrigenomic strategies

Summary

Introduction

Ingredients manufacturers approach to nutrigenomics

BASF

Chr Hansen

DSM

Food manufacturers’ approach to nutrigenomics

Group Danone

Nestlé

Unilever

Pharma industry M&A in consumer nutrition

The evolving open network model

Co-development opportunities

Areas for market growth & time scales

Conclusions

Chapter 5 Leading nutrigenomic testing companies

Summary

Introduction

Market leaders

23andme.com

GeneLink

Gene Smart

Genova Diagnostics

Interleukin Genetics Inc

WellGen Inc.

Conclusions

Chapter 6 Opportunities: convergence of pharma & diagnostics

Summary

Introduction

Nutrigenomics vs pharmacogenomics

Global health issues treatment vs prevention

Convergence of the pharmaceutical & diagnostic market

Conclusions

Chapter 7 Challenges: regulation, ethical & IP issues

Summary

Introduction

Regulation of nutrigenomic foods

Europe

Japan

Regulation of nutrigenomic tests

Ethical issues

Public awareness & perceptions

Intellectual Property

Conclusions

Chapter 8 Conclusions

Summary

The food & drinks market

Global genetic testing market

Market trends

Overall conclusions

Appendix

Primary research methodology

Acknowledgments

Glossary

Index

Bibliography

Endnotes

List of Figures

Figure 1.1: Nutrigenetics and nutrigenomics

Figure 1.2: The ‘omics technologies

Figure 1.3: The functional genomic tool box

Figure 1.4: Applications of nutrigenomics in the food chain

Figure 2.5: Drivers for the food & drinks industry

Figure 2.6: The ageing population a driver for personalized nutrition

Figure 2.7: Personalized nutrition targeting consumer segments

Figure 2.8: Population over 60: world and developed regions (1950-2050)

Figure 2.9: Nutritional challenges - obesity & metabolic syndrome

Figure 2.10: Growth in consumers in developing & emerging countries (2008-2018)

Figure 2.11: Healthcare expenditure as a share of GDP (2006)

Figure 2.12: Target population of nutrigenomic based products

Figure 4.13: BASF approach to gene discovery

Figure 4.14: DSMs sales growth targeting four emerging business areas

Figure 4.15 DSMs R&D competencies

Figure 4.16 An International and interdisciplinary network

Figure 4.17 Diversify & de-risk through externalization

Figure 4.18 Open network model

Figure 4.19: Waves of nutrigenomic development

Figure 5.20: WellGen’s nutrigenomic based discovery

Figure 6.21: Nutrigenomics vs pharmacogenomics

Figure 6.22: Relationship of drugs, disease, genes and gene products

Figure 8.23: Health and nutrition market segments (2009)

Figure 8.24: Nutrigenomic impact on personalized nutrition

List of Tables

Table 3.1: European Consortia and Nutrigenomic Research Programs

Table 3.2: Nutrigenomics Network Programs

Table 4.3: Stakeholders in nutrigenomic research and personalized nutrition

Table 4.4: Chr Hansen - strategic alliances & investments

Table 4.5: Nestlé nutrigenomic alliances & investments

Table 4.6: Divestment of Animal, Consumer & Medical Nutrition Divisions

Table 4.7: Consumer Health Divisions of Pharmaceutical Companies

Table 4.8: Alliance between Food, Pharma, Biotech and the Diagnostic Industries

Table 5.9: Categorization of genetic variations that may be included in nutrigenomic tests

Table 5.10: Categorization of genetic variations that may be included in nutrigenomic tests

Table 6.11: Known diet- gene interactions

Table 6.12: Known gene-nutrient interactions

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.